Best AI Postoperative AFib Prediction Tools for Cardiac Surgeons 2026

Postoperative atrial fibrillation (POAF) affects up to 40% of cardiac surgery patients, driving longer ICU stays, higher stroke risk, and increased costs. Traditional risk scores like CHA₂DS₂-VASc offer limited predictive power and miss many at-risk patients. AI prediction tools now analyze ECG waveforms, lab trends, and clinical variables in real time to identify high-risk patients before AF develops. These platforms integrate with existing EHR systems, run securely inside hospital firewalls, and are increasingly backed by regulatory clearances from the FDA and European MDR. For cardiac surgeons looking to reduce postoperative complications and improve outcomes, choosing the right AI prediction tool is a critical clinical decision.

Best overall: Anumana ECG-AI

Comparison Table

x-cardiac Platform

x-cardiac Platform is an MDR-certified Class IIa medical device that delivers real-time AI prediction of postoperative complications including atrial fibrillation after cardiac surgery. It analyzes clinical data directly from ICU admission to generate risk scores and enable rapid clinical intervention before AF develops. The platform integrates with existing hospital IT systems without requiring large-scale infrastructure projects, making deployment practical for busy heart surgery centers.

Best for: Cardiac surgeons and ICU teams at heart surgery centers needing real-time POAF risk stratification.

Pricing: Enterprise (custom pricing).

Try Tool: Try Xcardiac →

CardiacTools

CardiacTools is a precision cardiovascular hub that features a dedicated AI-powered POAF prediction engine with a real-time alert board for clinicians. It covers the full cardiac journey from prehabilitation through ICU to patient-facing tools, and uses an STS-compatible data schema for multi-centre benchmarking. The platform is designed for full team adoption across surgical, anaesthesia, and nursing staff, creating a unified workflow around AF risk management.

Best for: Cardiac surgery teams seeking an all-in-one perioperative platform with integrated AF risk alerts.

Pricing: Subscription-based (custom pricing).

Try Tool: Try Cardiactools →

Anumana ECG-AI

Anumana ECG-AI is an FDA-cleared platform that detects atrial fibrillation risk from standard 12-lead ECGs during sinus rhythm. Developed in partnership with Mayo Clinic using over 22 million patient records, it is supported by more than 100 peer-reviewed studies making it the most clinically validated option available today. The platform runs securely within the hospital environment with direct EHR integration, allowing seamless preoperative risk screening without additional hardware or complex setup.

Best for: Hospitals and health systems using preoperative ECG for automated AF risk screening.

Pricing: Enterprise pricing per algorithm.

Try Tool: Try Anumana →

PeriopAI

PeriopAI is an AI-powered clinical decision support platform for comprehensive perioperative risk assessment across the full care continuum. It uses a RAG-powered system incorporating the latest medical guidelines and research evidence to generate risk scores, and includes facility matching intelligence for optimal patient-to-hospital assignment. While broader in scope than dedicated POAF tools, its multi-phase approach provides valuable context for surgical decision-making across the entire perioperative timeline.

Best for: Perioperative care teams needing multi-phase risk stratification across pre-, intra-, and postoperative phases.

Pricing: Enterprise subscription.

Try Tool: Try Periopai →

Philips Cardiologs

Philips Cardiologs is an FDA-cleared and CE-marked deep learning ECG analysis solution trained on over 200 million recordings. It detects 20+ arrhythmia types including atrial fibrillation with 98.5% specificity, making it one of the most validated diagnostic tools in cardiology worldwide. As part of the Philips global healthcare ecosystem, it benefits from established hospital deployment channels and ongoing enterprise support across major markets.

Best for: Cardiac monitoring teams needing automated postoperative AF detection from Holter and ambulatory ECG.

Pricing: Per-study or subscription pricing.

Try Tool: Try Philips Cardiologs →

FAQ

What is postoperative atrial fibrillation (POAF)?

POAF is new-onset atrial fibrillation occurring after cardiac surgery, most commonly within the first week post-operation. It affects up to 40% of patients and is associated with increased stroke risk, prolonged ICU stays, and higher overall healthcare costs.

How do AI tools predict POAF risk before it develops?

AI prediction tools analyze preoperative 12-lead ECG patterns, intraoperative data, lab values, and patient demographics using deep learning models. They identify subtle electrocardiographic markers invisible to human interpretation and generate real-time risk scores at the point of care, enabling earlier intervention and tailored monitoring.

Do these AI prediction tools have regulatory approval for clinical use?

Yes. Anumana ECG-AI is FDA-cleared, x-cardiac Platform is MDR-certified as a Class IIa medical device in Europe, and Philips Cardiologs holds both FDA clearance and CE marking. Regulatory status varies by market and specific clinical indication, so verify availability in your region before purchasing.

Conclusion

AI-powered POAF prediction is rapidly becoming standard practice for cardiac surgical teams looking to reduce postoperative complications and improve patient outcomes. Anumana ECG-AI offers the highest rating and strongest clinical evidence base with FDA clearance, while x-cardiac Platform provides the most dedicated real-time POAF risk stratification tool with European MDR certification. Whichever platform you choose, integrating AI-driven prediction into your preoperative workflow can meaningfully reduce complication rates.

Start with the top-rated solution: Try Anumana →

This page contains affiliate links. We may earn a commission if you purchase through our links.